US 11345904
Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof
granted A61KA61K38/43A61K38/47
Quick answer
US patent 11345904 (Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof) held by BIOMARIN PHARMACEUTICAL INC. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/43, A61K38/47, A61K47/26, A61K47/65